Meta-analysis of frusemide to prevent or treat acute renal failure
about
The HELLP syndrome: clinical issues and management. A ReviewLoop diuretics for acute kidney injury in adults and childrenAcute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysisRenocardiac syndromes: physiopathology and treatment stratagemsCardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysisRenal oxygenation and haemodynamics in acute kidney injury and chronic kidney diseaseFluid balance, diuretic use, and mortality in acute kidney injury.Evaluation and initial management of acute kidney injury.PHARMACOLOGICAL TREATMENTS FOR TINNITUS: NEW AND OLDEmerging pharmacotherapy of tinnitus.Anesthetic considerations in HELLP syndrome.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Fluid balance and urine volume are independent predictors of mortality in acute kidney injury.Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.Serum creatinine role in predicting outcome after cardiac surgery beyond acute kidney injury.Care of the critically ill emergency department patient with acute kidney injuryEtiology and outcomes of anuria in acute kidney injury: a single center study.A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathyHigh Stroke Volume Variation Method by Mannitol Administration Can Decrease Blood Loss During Donor HepatectomyFluid Overload Is Associated With Late Poor Outcomes in Neonates Following Cardiac SurgeryThe kidney in the critically ill.Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix ProgrammMedical therapy of acute kidney injury.Furosemide is associated with acute kidney injury in critically ill patients.Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis.Perioperative intravenous fluid therapy for adults.Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation.Acute kidney injury: the beginning of the end of the dark agesRenal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation.Moving beyond supportive care--current status of specific therapies in pediatric acute kidney injury.Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations.Influence of oxygen content immediately after graft reperfusion on occurrence of postoperative acute kidney injury in living donor liver transplantation.Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review.Acute kidney injury in survivors of surgery for severe traumatic brain injury: Incidence, risk factors, and outcome from a tertiary neuroscience center in India.The Effect of Furosemide on the Level of Neutrophil Gelatinase-associated Lipocalin in Critically Hospitalized Patients with Acute Kidney InjuryCardiovascular medications among the critically ill patients of a tertiary care hospital: A drug utilization study.
P2860
Q21261342-D5F43339-B43C-497D-856E-CDA843841581Q24199039-0DF35813-94BC-4006-AADE-8986CF555342Q26745670-030BDD4E-AACB-443D-9FA7-3D32DE50518CQ26778569-F7624962-31D0-4A76-B7FA-B66A6A5CB501Q26781936-9B793EB2-8982-4105-94C4-F6B7E708E27AQ26851289-2741C265-BA57-496F-970B-CEDCE75E12FAQ26996101-589EBD35-2121-4B96-A7E9-F1711B380786Q30427055-D99373B5-32A2-4D6C-86EF-07415B9A0037Q30439287-BAB8F598-BEB6-4300-83BD-D6A6F07670A1Q30474822-2320404D-5758-46E2-98E8-0CE44B33103EQ30478378-EC1626C2-E984-4729-A8FE-8E6AE22E3054Q33426530-146A5755-56A7-427C-86BC-8C3F4535143EQ33753500-51947B68-88F3-46D7-A1C7-D8D557BEA009Q33754784-897E5873-25FF-41E3-AF49-A732A8B01D85Q33843623-8CF6A34A-9220-4642-A8DC-B08D71CC8B1CQ33869039-1D62B5B6-F6BF-4EBB-AC59-05CD243885B0Q34251828-2C91FBA6-3441-4263-9376-CCA62655924FQ35579290-38E0E89E-2145-4B75-8842-CB6A00F6A28EQ36061753-C746D463-5D54-4D37-A882-5FA749B1B336Q36460769-56D35F6A-42C5-4EE6-A9C3-620852D0236FQ36478041-86F9D8A0-E115-4541-A426-D03D10B373B6Q36869342-44604937-F233-4812-A62C-E40939A310E6Q36938144-766D4155-6E2C-46C2-9B7D-0DABCF8A34C8Q37023682-780CF410-2608-4ADA-A5D4-1D994EC97763Q37088297-E3E1E2D8-9528-4BD7-889A-C57F20F660FBQ37371269-BB74F66F-0669-401E-84C2-FEF8C6CC8461Q37478489-81E4C622-5BC4-4478-8A4F-9978A27172BFQ37553672-28A95D1F-C813-43ED-863A-D92575FCDB08Q37877721-5C0A368E-130F-485A-B089-AB2B244BD2A1Q37899942-A7EA9F03-181C-4E78-BA55-AE154EE8BB54Q37911897-E1E369CE-0F86-46CA-A1E8-BBA6F546E26EQ38002253-D396A045-C840-496B-8E21-F3A16AC382DEQ38081370-A51FD402-3C88-4B7E-B4B2-65F865C3BF0AQ38341214-282B133B-8FA5-427A-9264-7A8D698D27A3Q38407334-754DD7AB-9DF5-40FC-AA61-E195EA551FC1Q38646806-8FCBB2F1-4720-42A6-B408-D3780EDF2419Q38665661-3F129A2C-C354-43BD-9F38-64CCD3465330Q41182783-057A17CE-4E36-47B9-A5E2-CCC3CA5EB287Q41196850-48D89C55-1A7B-4704-8B77-B7675040C267Q41871637-8CF0196F-78FE-431C-941F-C42A2212D391
P2860
Meta-analysis of frusemide to prevent or treat acute renal failure
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Meta-analysis of frusemide to prevent or treat acute renal failure
@ast
Meta-analysis of frusemide to prevent or treat acute renal failure
@en
Meta-analysis of frusemide to prevent or treat acute renal failure
@nl
type
label
Meta-analysis of frusemide to prevent or treat acute renal failure
@ast
Meta-analysis of frusemide to prevent or treat acute renal failure
@en
Meta-analysis of frusemide to prevent or treat acute renal failure
@nl
prefLabel
Meta-analysis of frusemide to prevent or treat acute renal failure
@ast
Meta-analysis of frusemide to prevent or treat acute renal failure
@en
Meta-analysis of frusemide to prevent or treat acute renal failure
@nl
P2860
P3181
P1433
P1476
Meta-analysis of frusemide to prevent or treat acute renal failure
@en
P2093
David J Sheridan
P2860
P3181
P356
10.1136/BMJ.38902.605347.7C
P407
P50
P577
2006-08-26T00:00:00Z